Neogen Corporation (NASDAQ: NEOG) announced today that it has entered into a partnership with genetic testing company Gencove to develop Neogen’s next generation of animal genomic tests.
Gencove’s flagship product is its low-pass whole genome sequencing platform, which is a technology that has the potential to more accurately assess the genetic potential of an animal earlier in its life. Sequencing technology has the potential to provide more data, and more powerful discovery capabilities, than existing technology.
“The adoption of low-pass skim sequencing will be a great addition alongside our existing GeneSeek Genomic Profiler genotyping arrays, and ideally positions us and our customers for the future by leveraging this innovation,” said Dr. Stewart Bauck, Neogen’s vice president of agrigenomics. “Through this partnership, Neogen can begin to more fully explore bioinformatics that profile the full genome.”
As the global leader in animal genomics, Neogen will combine its world-wide presence, high throughput and focus on quality with this expanded product offering through the partnership with Gencove.
Want to publish your own articles on DistilINFO Publications?
Send us an email, we will get in touch with you.
Gencove offers both low pass sequencing and analytics software as a service, with sequencing as its flagship product. Trusted by researchers at leading genomics companies like BGI and leading academic institutions like the Broad Institute and the Weizmann Institute, Gencove provides these applications within the genomic fields of human, companion animal and agriculture.
“Our organization is dedicated to making genomic data more accessible and interpretable,” said Joe Pickrell, Gencove’s CEO and co-founder. “Partnering with Neogen, the largest genomic solutions service provider in agriculture worldwide, will give both our organizations the opportunity to advance the agricultural genomics industry by leading in the implementation of new technologies.”
Source: PR Newswire